标准化定位协议降低了与帕克利塔克塞尔输液相关的过敏反应的发生率
Kofi Sefah1, Karolina A Kilowski2, Sarah A Gifford1
1AdventHealth Pharmacy, Oncology Division, Orlando, FL.
JCO oncology practice
|October 31, 2023
概括
一个新的帕克利塔塞尔定位方案显著减少了接受输液的患者的过敏反应. 与标准护理相比,这种标准化的方法降低了反应率和严重程度,因此需要进一步调查.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 与输液相关的过敏反应在帕克利塔塞尔化疗中很常见.
- 目前的前期药物 (甲基沙,二胺) 并不能完全预防这些反应.
- 帕克利塔克塞尔定位方案是经验上得出的,缺乏III期试验验证.
研究的目的:
- 为了比较标准化帕克利塔塞尔定位方案和标准护理 (SOC) 输液方案之间的过敏反应的频率和严重程度.
主要方法:
- 451名接受第一个或第二次帕克利塔塞尔输液的患者的回顾性审查.
- 对标准化滴定方案的患者的反应与SOC输液方案的反应进行比较.
- 收集关于反应速率,时间,严重程度和前期药物使用的数据.
主要成果:
- 与SOC组 (18.3%) 相比,定位协议组显示过敏反应的发生率明显较低 (4.8%).
- 在定位组中消除了3级或更大的输液反应,而在SOC组中只有18%.
- 反应发生在输液周期的晚些时候,与定位协议.
结论:
- 一个标准化的帕克利塔塞尔定位方案显著减少了输注相关的过敏反应.
- 该协议可能为帕克利塔克塞尔的使用提供更安全的替代方案.
- 建议进行前性随机试验以验证这些发现.
相关概念视频
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...


